Global Blood Transfusion Market Size, Share & Trends Analysis 2024-2030 MedCore

In 2023, the global blood transfusion set market reported a total value of $480.1 million, reflecting a 3.5% decline from the $464.1 million recorded in 2022. However, projections for the upcoming period indicate a positive growth trajectory, with a compound annual growth rate (CAGR) of 3.0%, ultimately reaching $591 million. Currently, the global blood transfusion set market is under the dominion of Becton Dickinson (BD), Baxter, and ICU Medical.

Our comprehensive medical market research encompassed a thorough analysis of more than 15 blood transfusion companies across seven continents. Employing a rigorous methodology, we delved into market sizes, unit sales, company market shares, and generated precise forecasts.

DATA TYPES INCLUDED

• Unit Sales, Average Selling Prices, Market Value & Growth Trends
• Forecasts Until 2030, and Historical Data to 2020
• Market Drivers & Limiters for Each Segment
• Competitive Analysis with Market Shares for Each Segment
• Recent Mergers & Acquisitions

COVID-19 Impact

• Disease Overviews and Demographic Information
• Company Profiles, Product Portfolios and SWOT for Top Competitors

GLOBAL BLOOD TRANSFUSION MARKET INSIGHTS

The prevalence of chronic illnesses like cancer, cardiovascular diseases, and blood disorders is on the rise, leading to an increased need for regular blood transfusions as a crucial aspect of treatment. With the growing incidence of these conditions, the demand for blood transfusion kits becomes even more pronounced, serving as a lifeline for individuals grappling with these significant health challenges. The increasing prevalence of chronic diseases underscores the essential role played by blood transfusion kits in providing essential care and support to those in need, ultimately contributing to improved healthcare outcomes.

GLOBAL BLOOD TRANSFUSION MARKET SHARE INSIGHTS

Becton Dickinson (BD) secured its top position among competitors in the blood transfusion device market. BD offered a comprehensive range of blood IV sets, available in both pump-based and gravity-based configurations. These sets featured essential components such as a 180-µm filter, a pressure pump, a needleless connector, and male Luer lock adapters. They were specifically designed for use with BD's Alaris brand of infusion pumps. BD's presence in the IV set market was substantial, and in 2015, the company bolstered its industry standing by acquiring infusion therapy products from CareFusion.

Baxter held the second spot in the blood transfusion device market. The company provided a diverse array of blood collection and administration sets, including standard blood in-line filters, Y-sites, male Luer lock injection adapters, and a pressure pump. Baxter's robust position in both the IV set and infusion pump markets allowed them to drive sales of blood sets effectively. Their product lineup encompassed dual-chamber and single-chamber devices.

ICU Medical, ranking third among competitors in the blood transfusion device market, demonstrated particular strength in North America. The company boasted an extensive range of products and disposables within its infusion therapy portfolio, which was further expanded through the acquisition of Smiths Medical. ICU Medical offered transfusion sets compatible with both gravity and infusion pumps. Additionally, they provided three distinct blood collection and administration tubing options, along with associated accessories, as part of their Saf-T Wing™ product line.

MARKET SEGMENTATION SUMMARY

• Blood Transfusion Market